… Eligible participants included adults, 18–76 years of age who were previously diagnosed
with SARS-CoV-2 by RT–PCR or through a combination of clinical symptoms consistent with …

… -2 spike receptor-binding domain (RBD) that escape binding by a leading monoclonal
antibody, LY-CoV555, and its cocktail combination with LY-CoV016. Individual mutations that …

… COV2-2130 (cilgavimab) and its combination with COV2-2196 (tixagevimab) retained activity
against BA.2, but this antibody combination is authorized only for preventive use. Only the …

… or combinations of antibody classes are … antibody responses in SARS-CoV-2 infection,
but the waning IgG titers demonstrated in this study are in contrast to SARS-CoV and MERS-CoV …

… We also tested the antibodies in combination to mimic the therapeutic cocktails. Bamlanivimab
+ etesevimab (Lilly) or casirivimab + imdevimab (Ronapreve) were inactive against …

… We present estimates of sensitivity and specificity for each antibody (or combination of
antibodies) using paired forest plots, and also summarised them in tables as appropriate. …

… To determine the nature of the antibodies elicited by SARS-CoV-2 infection, we used flow …
Finally, antibodies with recurrent combinations of IGHV and IGLV genes were among the …

… Last, we assessed combinations of monoclonal antibodies and found several, … antibody
combinations that can be used for treatment and have demonstrated how these combinations …

… introduced antibody and vaccine countermeasures. Here, using monoclonal antibodies (…
, we report the impact on antibody neutralization of a panel of authentic SARS-CoV-2 variants …

… These MAb therapeutics are solely targeting the receptor-binding domain of the SARS-CoV-2 …
We report that a combination of two neutralizing antibodies targeting the receptor-binding …